{"id":11096,"date":"2025-10-28T17:36:32","date_gmt":"2025-10-28T16:36:32","guid":{"rendered":"https:\/\/rvh-synergie.org\/actualites\/un-nouvel-outil-clinique-peut-mesurer-la-gravite-des-troubles-cutanes-debilitants\/"},"modified":"2025-10-28T17:36:33","modified_gmt":"2025-10-28T16:36:33","slug":"un-nouvel-outil-clinique-peut-mesurer-la-gravite-des-troubles-cutanes-debilitants","status":"publish","type":"post","link":"https:\/\/rvh-synergie.org\/actualites\/un-nouvel-outil-clinique-peut-mesurer-la-gravite-des-troubles-cutanes-debilitants\/","title":{"rendered":"Un nouvel outil clinique peut mesurer la gravit\u00e9 des troubles cutan\u00e9s d\u00e9bilitants"},"content":{"rendered":"<div>\n<div class=\"article-gallery lightGallery\">\n<div data-thumb=\"https:\/\/scx1.b-cdn.net\/csz\/news\/tmb\/2025\/skin-2.jpg\" data-src=\"https:\/\/scx2.b-cdn.net\/gfx\/news\/hires\/2025\/skin-2.jpg\" data-sub-html=\"Credit: Jo\u00e3o Jesus from Pexels\">\n<figure class=\"article-img\">\n<\/figure><\/div>\n<\/div>\n<p>Un nouvel outil clinique pourrait am\u00e9liorer la fa\u00e7on dont les m\u00e9decins \u00e9valuent la gravit\u00e9 d&rsquo;une maladie cutan\u00e9e douloureuse et souvent d\u00e9bilitante, selon une \u00e9tude r\u00e9cemment publi\u00e9e dans <i>JAMA Dermatologie.<\/i><\/p>\n<p>L&rsquo;\u00e9pidermolyse bulleuse simple (EBS) est le sous-type le plus courant d&rsquo;\u00e9pidermolyse bulleuse (EB), un groupe d&rsquo;affections cutan\u00e9es h\u00e9r\u00e9ditaires caract\u00e9ris\u00e9es par des cloques et une fragilit\u00e9 cutan\u00e9e. Malgr\u00e9 sa pr\u00e9valence, il n\u2019existe aucun traitement approuv\u00e9 par la Food and Drug Administration des \u00c9tats-Unis pour l\u2019EBS, et les cliniciens manquaient jusqu\u2019\u00e0 pr\u00e9sent d\u2019une m\u00e9thode standardis\u00e9e pour mesurer la gravit\u00e9 de la maladie.<\/p>\n<p>\u00ab\u00a0Nous n&rsquo;avons pas de th\u00e9rapies pour ces patients, donc des \u00e9tudes comme celle-ci visent \u00e0 trouver des moyens d&rsquo;am\u00e9liorer la qualit\u00e9 de vie et de trouver des traitements \u00e0 l&rsquo;avenir\u00a0\u00bb, a d\u00e9clar\u00e9 Amy Paller, MS, MD, &rsquo;81, &rsquo;83 GME, pr\u00e9sidente et professeur de dermatologie Walter J. Hamlin, co-auteur de l&rsquo;\u00e9tude. \u00ab\u00a0Auparavant, les soci\u00e9t\u00e9s pharmaceutiques menant des essais cliniques ne disposaient d&rsquo;aucun outil sp\u00e9cifique pour mesurer cela.\u00a0\u00bb<\/p>\n<p>Dans la pr\u00e9sente \u00e9tude, des enqu\u00eateurs de sites m\u00e9dicaux \u00e0 travers le pays ont analys\u00e9 un r\u00e9f\u00e9rentiel de 130 photographies cliniques de 80 patients EBS g\u00e9n\u00e9tiquement confirm\u00e9s, capturant une gamme de gravit\u00e9s de maladies dans cinq r\u00e9gions anatomiques. Neuf dermatologues certifi\u00e9s ont not\u00e9 les images \u00e0 l&rsquo;aide d&rsquo;une \u00e9chelle de 5 points, \u00e9valuant des caract\u00e9ristiques telles que des cloques, des \u00e9rosions et une k\u00e9ratodermie.<\/p>\n<p>Ils ont ensuite compar\u00e9 les \u00e9chelles et ont constat\u00e9 qu\u2019il y avait un fort accord entre les dermatologues \u00e9valuateurs. En utilisant ce consensus, les enqu\u00eateurs ont ensuite d\u00e9velopp\u00e9 l&rsquo;outil d&rsquo;activit\u00e9 et de r\u00e9ponse \u00e0 la maladie de l&rsquo;\u00e9pidermolyse bulleuse simplex (EBSdart), une \u00e9chelle con\u00e7ue sp\u00e9cifiquement pour \u00e9valuer les principales caract\u00e9ristiques de l&rsquo;EBS.<\/p>\n<p>Le nouvel outil fournira une \u00e9chelle de gravit\u00e9 fiable et sp\u00e9cifique \u00e0 la maladie, ce qui permettra un suivi plus pr\u00e9cis de la progression de la maladie et de la r\u00e9ponse aux futurs traitements, a d\u00e9clar\u00e9 Paller.<\/p>\n<p>\u00ab\u00a0Le fait de disposer de cet outil standardis\u00e9 conf\u00e8re une plus grande pr\u00e9cision aux r\u00e9sultats des essais cliniques li\u00e9s \u00e0 l&rsquo;EBS. Nous esp\u00e9rons que nos r\u00e9sultats utilisant ce nouvel outil refl\u00e9teront des r\u00e9sultats plus significatifs et un cheminement plus rapide vers l&rsquo;approbation et la commercialisation des traitements par la FDA\u00a0\u00bb, a d\u00e9clar\u00e9 Paller.<\/p>\n<p>S&rsquo;appuyant sur le nouveau syst\u00e8me de notation, Paller et ses collaborateurs m\u00e8nent plusieurs essais cliniques \u00e0 l&rsquo;aide de l&rsquo;outil, qui, esp\u00e8rent-ils, acc\u00e9l\u00e9reront le d\u00e9veloppement de nouveaux traitements pour cette maladie.<\/p>\n<p>                                        <!-- print only --><\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Un nouvel outil clinique pourrait am\u00e9liorer la fa\u00e7on dont les m\u00e9decins \u00e9valuent la gravit\u00e9 d&rsquo;une<\/p>\n","protected":false},"author":1,"featured_media":9501,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[86],"tags":[733,7376,7377,16,1373,3912,1760,568,669,164],"class_list":["post-11096","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-les-maladies","tag-clinique","tag-cutanes","tag-debilitants","tag-des","tag-gravite","tag-mesurer","tag-nouvel","tag-outil","tag-peut","tag-troubles","generate-columns","tablet-grid-50","mobile-grid-100","grid-parent","grid-50","resize-featured-image"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Un nouvel outil clinique peut mesurer la gravit\u00e9 des troubles cutan\u00e9s d\u00e9bilitants - RVH-Synergie.org<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/rvh-synergie.org\/actualites\/un-nouvel-outil-clinique-peut-mesurer-la-gravite-des-troubles-cutanes-debilitants\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Un nouvel outil clinique peut mesurer la gravit\u00e9 des troubles cutan\u00e9s d\u00e9bilitants - RVH-Synergie.org\" \/>\n<meta property=\"og:description\" content=\"Un nouvel outil clinique pourrait am\u00e9liorer la fa\u00e7on dont les m\u00e9decins \u00e9valuent la gravit\u00e9 d&rsquo;une\" \/>\n<meta property=\"og:url\" content=\"https:\/\/rvh-synergie.org\/actualites\/un-nouvel-outil-clinique-peut-mesurer-la-gravite-des-troubles-cutanes-debilitants\/\" \/>\n<meta property=\"og:site_name\" content=\"RVH-Synergie\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-28T16:36:32+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-28T16:36:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/09\/1757973656_Le-diabete-de-type-2-peut-double-risque-de-septicemie-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1707\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Charles Martinez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Charles Martinez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/un-nouvel-outil-clinique-peut-mesurer-la-gravite-des-troubles-cutanes-debilitants\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/un-nouvel-outil-clinique-peut-mesurer-la-gravite-des-troubles-cutanes-debilitants\/\"},\"author\":{\"name\":\"Charles Martinez\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/aa5ea98671fb4e8620f488a0795d2560\"},\"headline\":\"Un nouvel outil clinique peut mesurer la gravit\u00e9 des troubles cutan\u00e9s d\u00e9bilitants\",\"datePublished\":\"2025-10-28T16:36:32+00:00\",\"dateModified\":\"2025-10-28T16:36:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/un-nouvel-outil-clinique-peut-mesurer-la-gravite-des-troubles-cutanes-debilitants\/\"},\"wordCount\":478,\"publisher\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#organization\"},\"image\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/un-nouvel-outil-clinique-peut-mesurer-la-gravite-des-troubles-cutanes-debilitants\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/09\/1757973656_Le-diabete-de-type-2-peut-double-risque-de-septicemie-scaled.jpg\",\"keywords\":[\"clinique\",\"cutan\u00e9s\",\"d\u00e9bilitants\",\"des\",\"gravit\u00e9\",\"mesurer\",\"nouvel\",\"outil\",\"peut\",\"troubles\"],\"articleSection\":[\"Les maladies\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/un-nouvel-outil-clinique-peut-mesurer-la-gravite-des-troubles-cutanes-debilitants\/\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/un-nouvel-outil-clinique-peut-mesurer-la-gravite-des-troubles-cutanes-debilitants\/\",\"name\":\"Un nouvel outil clinique peut mesurer la gravit\u00e9 des troubles cutan\u00e9s d\u00e9bilitants - RVH-Synergie.org\",\"isPartOf\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/un-nouvel-outil-clinique-peut-mesurer-la-gravite-des-troubles-cutanes-debilitants\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/un-nouvel-outil-clinique-peut-mesurer-la-gravite-des-troubles-cutanes-debilitants\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/09\/1757973656_Le-diabete-de-type-2-peut-double-risque-de-septicemie-scaled.jpg\",\"datePublished\":\"2025-10-28T16:36:32+00:00\",\"dateModified\":\"2025-10-28T16:36:33+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/un-nouvel-outil-clinique-peut-mesurer-la-gravite-des-troubles-cutanes-debilitants\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/rvh-synergie.org\/actualites\/un-nouvel-outil-clinique-peut-mesurer-la-gravite-des-troubles-cutanes-debilitants\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/un-nouvel-outil-clinique-peut-mesurer-la-gravite-des-troubles-cutanes-debilitants\/#primaryimage\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/09\/1757973656_Le-diabete-de-type-2-peut-double-risque-de-septicemie-scaled.jpg\",\"contentUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/09\/1757973656_Le-diabete-de-type-2-peut-double-risque-de-septicemie-scaled.jpg\",\"width\":2560,\"height\":1707,\"caption\":\"Le diab\u00e8te de type 2 peut double risque de septic\u00e9mie, sugg\u00e8rent une grande \u00e9tude communautaire\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/un-nouvel-outil-clinique-peut-mesurer-la-gravite-des-troubles-cutanes-debilitants\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/rvh-synergie.org\/actualites\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Un nouvel outil clinique peut mesurer la gravit\u00e9 des troubles cutan\u00e9s d\u00e9bilitants\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#website\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/\",\"name\":\"RVH-Synergie.org\",\"description\":\"RVH-Synergie, site ind\u00e9pendant d&#039;informations sur la prise en charge des addictions.\",\"publisher\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/rvh-synergie.org\/actualites\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#organization\",\"name\":\"RVH-Synergie.org\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png\",\"contentUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png\",\"width\":512,\"height\":512,\"caption\":\"RVH-Synergie.org\"},\"image\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/aa5ea98671fb4e8620f488a0795d2560\",\"name\":\"Charles Martinez\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg\",\"contentUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg\",\"caption\":\"Charles Martinez\"},\"description\":\"Bonjour, je m'appelle Charles Martinez, r\u00e9dacteur passionn\u00e9 pour le m\u00e9dia RVH-synergie.org, d\u00e9di\u00e9 aux addictions et aux maladies. Depuis plus de dix ans, j'explore et rapporte les histoires poignantes des individus confront\u00e9s \u00e0 ces d\u00e9fis, tout en sensibilisant le public aux traitements novateurs et aux progr\u00e8s scientifiques dans ce domaine. Mon engagement r\u00e9side dans l'espoir de cr\u00e9er une communaut\u00e9 inform\u00e9e et empathique, pr\u00eate \u00e0 soutenir ceux qui luttent contre ces \u00e9preuves.\",\"sameAs\":[\"https:\/\/rvh-synergie.org\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Un nouvel outil clinique peut mesurer la gravit\u00e9 des troubles cutan\u00e9s d\u00e9bilitants - RVH-Synergie.org","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/rvh-synergie.org\/actualites\/un-nouvel-outil-clinique-peut-mesurer-la-gravite-des-troubles-cutanes-debilitants\/","og_locale":"fr_FR","og_type":"article","og_title":"Un nouvel outil clinique peut mesurer la gravit\u00e9 des troubles cutan\u00e9s d\u00e9bilitants - RVH-Synergie.org","og_description":"Un nouvel outil clinique pourrait am\u00e9liorer la fa\u00e7on dont les m\u00e9decins \u00e9valuent la gravit\u00e9 d&rsquo;une","og_url":"https:\/\/rvh-synergie.org\/actualites\/un-nouvel-outil-clinique-peut-mesurer-la-gravite-des-troubles-cutanes-debilitants\/","og_site_name":"RVH-Synergie","article_published_time":"2025-10-28T16:36:32+00:00","article_modified_time":"2025-10-28T16:36:33+00:00","og_image":[{"width":2560,"height":1707,"url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/09\/1757973656_Le-diabete-de-type-2-peut-double-risque-de-septicemie-scaled.jpg","type":"image\/jpeg"}],"author":"Charles Martinez","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Charles Martinez","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/rvh-synergie.org\/actualites\/un-nouvel-outil-clinique-peut-mesurer-la-gravite-des-troubles-cutanes-debilitants\/#article","isPartOf":{"@id":"https:\/\/rvh-synergie.org\/actualites\/un-nouvel-outil-clinique-peut-mesurer-la-gravite-des-troubles-cutanes-debilitants\/"},"author":{"name":"Charles Martinez","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/aa5ea98671fb4e8620f488a0795d2560"},"headline":"Un nouvel outil clinique peut mesurer la gravit\u00e9 des troubles cutan\u00e9s d\u00e9bilitants","datePublished":"2025-10-28T16:36:32+00:00","dateModified":"2025-10-28T16:36:33+00:00","mainEntityOfPage":{"@id":"https:\/\/rvh-synergie.org\/actualites\/un-nouvel-outil-clinique-peut-mesurer-la-gravite-des-troubles-cutanes-debilitants\/"},"wordCount":478,"publisher":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#organization"},"image":{"@id":"https:\/\/rvh-synergie.org\/actualites\/un-nouvel-outil-clinique-peut-mesurer-la-gravite-des-troubles-cutanes-debilitants\/#primaryimage"},"thumbnailUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/09\/1757973656_Le-diabete-de-type-2-peut-double-risque-de-septicemie-scaled.jpg","keywords":["clinique","cutan\u00e9s","d\u00e9bilitants","des","gravit\u00e9","mesurer","nouvel","outil","peut","troubles"],"articleSection":["Les maladies"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/rvh-synergie.org\/actualites\/un-nouvel-outil-clinique-peut-mesurer-la-gravite-des-troubles-cutanes-debilitants\/","url":"https:\/\/rvh-synergie.org\/actualites\/un-nouvel-outil-clinique-peut-mesurer-la-gravite-des-troubles-cutanes-debilitants\/","name":"Un nouvel outil clinique peut mesurer la gravit\u00e9 des troubles cutan\u00e9s d\u00e9bilitants - RVH-Synergie.org","isPartOf":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#website"},"primaryImageOfPage":{"@id":"https:\/\/rvh-synergie.org\/actualites\/un-nouvel-outil-clinique-peut-mesurer-la-gravite-des-troubles-cutanes-debilitants\/#primaryimage"},"image":{"@id":"https:\/\/rvh-synergie.org\/actualites\/un-nouvel-outil-clinique-peut-mesurer-la-gravite-des-troubles-cutanes-debilitants\/#primaryimage"},"thumbnailUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/09\/1757973656_Le-diabete-de-type-2-peut-double-risque-de-septicemie-scaled.jpg","datePublished":"2025-10-28T16:36:32+00:00","dateModified":"2025-10-28T16:36:33+00:00","breadcrumb":{"@id":"https:\/\/rvh-synergie.org\/actualites\/un-nouvel-outil-clinique-peut-mesurer-la-gravite-des-troubles-cutanes-debilitants\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/rvh-synergie.org\/actualites\/un-nouvel-outil-clinique-peut-mesurer-la-gravite-des-troubles-cutanes-debilitants\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/rvh-synergie.org\/actualites\/un-nouvel-outil-clinique-peut-mesurer-la-gravite-des-troubles-cutanes-debilitants\/#primaryimage","url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/09\/1757973656_Le-diabete-de-type-2-peut-double-risque-de-septicemie-scaled.jpg","contentUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/09\/1757973656_Le-diabete-de-type-2-peut-double-risque-de-septicemie-scaled.jpg","width":2560,"height":1707,"caption":"Le diab\u00e8te de type 2 peut double risque de septic\u00e9mie, sugg\u00e8rent une grande \u00e9tude communautaire"},{"@type":"BreadcrumbList","@id":"https:\/\/rvh-synergie.org\/actualites\/un-nouvel-outil-clinique-peut-mesurer-la-gravite-des-troubles-cutanes-debilitants\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/rvh-synergie.org\/actualites\/"},{"@type":"ListItem","position":2,"name":"Un nouvel outil clinique peut mesurer la gravit\u00e9 des troubles cutan\u00e9s d\u00e9bilitants"}]},{"@type":"WebSite","@id":"https:\/\/rvh-synergie.org\/actualites\/#website","url":"https:\/\/rvh-synergie.org\/actualites\/","name":"RVH-Synergie.org","description":"RVH-Synergie, site ind\u00e9pendant d&#039;informations sur la prise en charge des addictions.","publisher":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/rvh-synergie.org\/actualites\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/rvh-synergie.org\/actualites\/#organization","name":"RVH-Synergie.org","url":"https:\/\/rvh-synergie.org\/actualites\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/","url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png","contentUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png","width":512,"height":512,"caption":"RVH-Synergie.org"},"image":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/aa5ea98671fb4e8620f488a0795d2560","name":"Charles Martinez","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/image\/","url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg","contentUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg","caption":"Charles Martinez"},"description":"Bonjour, je m'appelle Charles Martinez, r\u00e9dacteur passionn\u00e9 pour le m\u00e9dia RVH-synergie.org, d\u00e9di\u00e9 aux addictions et aux maladies. Depuis plus de dix ans, j'explore et rapporte les histoires poignantes des individus confront\u00e9s \u00e0 ces d\u00e9fis, tout en sensibilisant le public aux traitements novateurs et aux progr\u00e8s scientifiques dans ce domaine. Mon engagement r\u00e9side dans l'espoir de cr\u00e9er une communaut\u00e9 inform\u00e9e et empathique, pr\u00eate \u00e0 soutenir ceux qui luttent contre ces \u00e9preuves.","sameAs":["https:\/\/rvh-synergie.org\/"]}]}},"_links":{"self":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/posts\/11096","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/comments?post=11096"}],"version-history":[{"count":0,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/posts\/11096\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/media\/9501"}],"wp:attachment":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/media?parent=11096"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/categories?post=11096"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/tags?post=11096"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}